North America Continuous Glucose Monitoring Systems (CGMS) Market

North America Continuous Glucose Monitoring Systems (CGMS) Market Overview

The Continuous Glucose Monitoring Systems (CGMS) devices have witnessed continuous technological evolution CGMS with smartphone connectivity. Wearable CGMS is another promising product with tremendous potential within the wearable healthcare devices. Non-invasive CGMS such as Symphony CGM System, due to its user-friendliness, extensive applications and FDA approvals for the same, have gained prominence over the years. Bionic pancreas is another notable product which is a smart and a complete diabetes management solution which is majorly used for Type I diabetes patients, is another notable breakthrough within the CGMS market.

The component segment of the CGMS market includes transmitters and receivers, sensors and CGMS compatible insulin pumps. Sensors market was the major segment with largest market share in 2015 and is anticipated to register a CAGR of 39% during the forecast period.

North America Continuous Glucose Monitoring Systems (CGMS) Market Segmentation

The report highlights the adoption of Continuous Glucose Monitoring Systems (CGMS) in North America.Based on the Component, the Global Continuous Glucose Monitoring Systems Market is segmented into Sensors, Transmitters & Receivers and Integrated Insulin pumps segment. Based on the End user, the market is bifurcated into Diagnostic centers/clinics, ICUs and Home Healthcare segments. The countries included in the report are U.S, Canada, Mexico and Rest of North America region.

North America Continuous Glucose Monitoring Systems (CGMS) Market Key Companies

Key Players profiled in the report includes Roche Diagnostics, Abbott Laboratories, Dexcom Inc., Novo Nordisk, Ypsomed AG, GlySens Incorporated, Medtronic Plc and Johnson & Johnson.

Research Scope

The market is segmented based on Component, End User and Country.

North America Continuous Glucose Monitoring Systems (CGMS) Market Segmentation

North America Continuous Glucose Monitoring Systems Market, by Component

• Hardware
• Software
• Services

North America Continuous Glucose Monitoring Systems Market, by End User

• Displays Terminals
• Interface Software
• Industrial PCs
• Other Controllers

North America Continuous Glucose Monitoring Systems Market, by Country

• U.S
• Canada
• Mexico
• Rest of North America

Company Profiles

• Roche Diagnostics
• Abbott Laboratories
• Dexcom Inc.
• Novo Nordisk
• Ypsomed AG
• GlySens Incorporated
• Medtronic Plc and
• Johnson & Johnson

Unique Offerings from KBV Research

• Exhaustive coverage of North America Continuous Glucose Monitoring Systems (CGMS) Market
• Unique “Market Research & Analytics Tool” to provide instant comparative analysis within the report
• Subscription based model available
• Free of cost quarterly updates
• Free of cost automatic pdf report generation
• Guaranteed best price
• Assured post sales research support with 10% customization free

Chapter 1-Market Scope & Methodology

1.1  Market Definition

1.2  Objectives

1.3  Market Scope

1.4  Segmentation

1.4.1  North America Continuous Glucose Monitoring Systems Market, by Component

1.4.2  North America Continuous Glucose Monitoring Systems Market, by End User

1.4.3  North America Continuous Glucose Monitoring Systems Market, by Country

1.5  Methodology for the research

Chapter 2.  Market Overview

2.1  Introduction

2.2  Key Influencing Factors

2.2.1  Drivers

2.2.2  Restraints

2.2.3  Opportunities

2.3  North America Continuous Glucose Monitoring Systems Market – By Country

Chapter 3.  North America Continuous Glucose Monitoring Systems Market – By Component

3.1  North America Continuous Glucose Monitoring Systems Sensors Market – By Country

3.2  North America Continuous Glucose Monitoring Transmitters & Receivers Market – By Country

3.3  North America Continuous Glucose Monitoring Systems Integrated Insulin pumps Market – By Country

Chapter 4.  North America Continuous Glucose Monitoring Systems Market – By End User

4.1  North America Diagnostic centers/clinics Continuous Glucose Monitoring Systems Market – By Country

4.2  North America ICUs Continuous Glucose Monitoring Systems Market – By Country

4.3  North America Home Healthcare Continuous Glucose Monitoring Systems Market – By Country

Chapter 5.  North America Continuous Glucose Monitoring Systems Market – By Country

5.1  U.S Continuous Glucose Monitoring Systems Market

5.1.1  U.S Continuous Glucose Monitoring Systems Market – By Component

5.1.2  U.S Continuous Glucose Monitoring Systems Market – By End User

5.2  Canada Continuous Glucose Monitoring Systems Market

5.2.1  Canada Continuous Glucose Monitoring Systems Market – By Component

5.2.2  Canada Continuous Glucose Monitoring Systems Market – By End User

5.3  Mexico Continuous Glucose Monitoring Systems Market

5.3.1  Mexico Continuous Glucose Monitoring Systems Market – By Component

5.3.2  Mexico Continuous Glucose Monitoring Systems Market – By End User

5.4  Rest of North America Continuous Glucose Monitoring Systems Market

5.4.1  Rest of North America Continuous Glucose Monitoring Systems Market – By Component

5.4.2  Rest of North America Continuous Glucose Monitoring Systems Market – By End User

Chapter 6.  Company Profile

6.1  Roche Diagnostics.

6.1.1  Company Overview

6.1.2  Financial Analysis

6.1.3  Segmental Analysis

6.1.4  Research & Development Analysis

6.2  Abbott Laboratories

6.2.1  Company Overview

6.2.2  Financial Analysis

6.2.3  Segmental Analysis

6.2.4  Research & Development Analysis

6.3  Dexcom, Inc.

6.3.1  Company Overview

6.3.2  Financial Analysis

6.3.3  Research & Development Analysis

6.4  Novo Nordisk.

6.4.1  Company Overview

6.4.2  Financial Analysis

6.4.3  Segmental Analysis

6.4.4  Research & Development Analysis

6.5  Ypsomed AG

6.5.1  Company Overview

6.5.2  Financial Analysis

6.5.3  Segmental Analysis

6.6  GlySens Incorporated.

6.6.1  Company Overview

6.7  Medtronic Plc

6.7.1  Company Overview

6.7.2  Financial Analysis

6.7.3  Segmental Analysis

6.7.4  Research & Development Analysis

6.8  Johnson & Johnson.

6.8.1  Company Overview

6.8.2  Financial Analysis

6.8.3  Research & Development Analysis

6.8.4  Segmental Analysis

List of Tables

TABLE 1  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 2  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 3  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 4  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 5  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 6  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 7  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 8  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS SENSORS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 9  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 10  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING TRANSMITTERS & RECEIVERS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 11  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 12  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS INTEGRATED INSULIN PUMPS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 13  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 14  NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 15  NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 16  NORTH AMERICA DIAGNOSTIC CENTERS/CLINICS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 17  NORTH AMERICA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 18  NORTH AMERICA ICUS CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 19  NORTH AMERICA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2012-2015

TABLE 20  NORTH AMERICA HOME HEALTHCARE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COUNTRY ($MILLION): 2016-2022

TABLE 21  U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 22  U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 23  U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 24  U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 25  U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 26  U.S CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 27  CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 28  CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 29  CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 30  CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 31  CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 32  CANADA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 33  MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 34  MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 35  MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 36  MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 37  MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 38  MEXICO CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 39  REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2012-2015

TABLE 40  REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET ($MILLION): 2016-2022

TABLE 41  REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2012-2015

TABLE 42  REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY COMPONENT ($MILLION): 2016-2022

TABLE 43  REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2012-2015

TABLE 44  REST OF NORTH AMERICA CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET – BY END USER ($MILLION): 2016-2022

TABLE 45  KEY INFORMATION – ROCHE DIAGNOSTICS.

TABLE 46  KEY INFORMATION – ABBOTT LABORATORIES.

TABLE 47  KEY INFORMATION – DEXCOM, INC.

TABLE 48  KEY INFORMATION – NOVO NORDISK.

TABLE 49  KEY INFORMATION – YPSOMED AG.

TABLE 50  KEY INFORMATION – GLYSENS INCORPORATED.

TABLE 51  KEY INFORMATION – MEDTRONIC PLC

TABLE 52  KEY INFORMATION – JOHNSON & JOHNSON.